We challenge systemic injustice and advocate for health equity in drug development and access.
Why Now is the Time
We all deserve a medicines system that protects equally
Millions of lives are lost because of an unjust system that prevents those most vulnerable from getting the medicines they need. Scientific breakthroughs may lead to drug treatments and vaccines for some, but not all.
What is Health Equity?Drug Pricing
Global
Racial
With nearly 20 years experience litigating and winning cases for health justice around the world.
I-MAK is positioned to change an outdated medicine system,
and partner with organizations committed to systemic change at every level.
We’ve been working to restore integrity to patent systems
for over a decade. So far, we’ve worked in 49 countries,
and improved the lives of people in over 70% of countries worldwide.
Our work
Countries Impacted
How excessive pharmaceutical patenting is extending monopolies and driving up drug prices.
Featured in the New York Times and NBC News
This database is user-friendly tool with comprehensive patent data on the ten top selling drugs
A simple and easy resource that provides patent, pricing, spending, and market data for the ten top selling drugs in America.
Study highlights excessive patenting practices on blockbuster drugs, such as Revlimid, Humira and Enbrel, which impact cancer and arthritis.
Through research, education, and policy, I-MAK is committed to finding solutions to address structural inequity in the medicines system.
Our team of lawyers, scientists, and global health experts empowers us to focus in three critical areas:
Research to
Influence Policy
Education to
Activate Change
Partnerships that
Drive Solutions
Partner with us now to build
a more just and equitable
medicine system for all.